Androgenetic alopecia and risk of prostate cancer: A systematic review and meta-analysis

Journal of the American Academy of Dermatology

Volumn 68, Issue 6, 2013, Pages 937-943

  Amoretti, Aline ^a   Laydner, Humberto ^a   Bergfeld, Wilma ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

androgenetic alopecia; baldness; hair loss; meta analysis; prostate cancer; systematic review

Indexed keywords

ALOPECIA; ARTICLE; CANCER RISK; COCHRANE LIBRARY; HAIR LOSS; HAMILTON SCALE; HUMAN; MALE TYPE ALOPECIA; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; SYSTEMATIC REVIEW;

ALOPECIA; CASE-CONTROL STUDIES; COMORBIDITY; HUMANS; MALE; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 84877801907     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.11.034     Document Type: Article

References (24)

1. S. Inui, and S. Itami Molecular basis of androgenic alopecia: from androgen to paracrine mediators through dermal papilla J Dermatol Sci 61 2011 1 6
2. M. Yassa, M. Saliou, Y. De Rycke, C. Hemery, M. Henni, and J.M. Bachaud Male pattern baldness and the risk of prostate cancer Ann Oncol 22 2011 1824 1827
3. J.A. Ellis, M. Stebbing, and S.B. Harrap Polymorphism of the androgen receptor gene is associated with male pattern baldness J Invest Dermatol 116 2001 452 455
4. J.L. Wright, S.T. Page, D.W. Lin, and J.L. Stanford Male pattern baldness and prostate cancer risk in a population-based case-control study Cancer Epidemiol 34 2010 131 135
5. E. Hawk, R.A. Breslow, and B.I. Graubard Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first national health and nutrition examination survey Cancer Epidemiol Biomarkers Prev 9 2000 523 527
6. W. Demark-Wahnefried, S.M. Lesko, M.R. Conaway, C.N. Robertson, R.V. Clark, and B. Lobaugh Serum androgens: associations with prostate cancer risk and hair patterning J Androl 18 1997 495 500
7. W. Denmark-Wahnefried, J.M. Schildkraut, D. Thompson, S.M. Lesko, L. McIntyre, and P. Schwingl Early-onset baldness and prostate cancer risk Cancer Epidemiol Biomarkers Prev 9 2000 325 328
8. G.G. Giles, G. Severi, R. Sinclair, D.R. English, M.R. McCredie, and W. Johnson Androgenetic alopecia and prostate cancer: findings from an Australian case-control study Cancer Epidemiol Biomarkers Prev 11 2002 549 553
9. G. Faydaci, E. Bilal, P. Necmettin, T. Fatih, O. Asuman, and K. Uǧur Baldness, benign prostate hyperplasia, prostate cancer and androgen levels Aging Male 11 2008 189 192
10. R.G. Cremers, K.K. Aben, S.H. Vermeulen, M. den Heijer, I.M. van Oort, and L.A. Kiemeney Androgenic alopecia is not useful as an indicator of men at high risk of prostate cancer Eur J Cancer 46 2010 3294 3299
11. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269
12. D.F. Stroup, J.A. Berlin, S.C. Morton, I. Olkin, G.D. Williamson, and D. Rennie Meta-analysis of observational studies in epidemiology: a proposal for reporting; meta-analysis of observational studies in epidemiology (MOOSE) group JAMA 283 2000 2008 2012
13. S. Arias-Santiago, M.A. Arrabal-Polo, A. Buendía-Eisman, M. Arrabal-Martín, M.T. Gutiérrez-Salmerón, and M.S. Girón-Prieto Androgenetic alopecia as an early marker of benign prostatic hyperplasia J Am Acad Dermatol 66 2012 401 408
14. L.B. Signorello, J. Wuu, C. Hsieh, A. Tzonou, D. Trichopoulos, and C.S. Mantzoros Hormones and hair patterning in men: a role for insulin-like growth factor 1? J Am Acad Dermatol 40 1999 200 203
15. A.G. Renehan, M. Zwahlen, C. Minder, S.T. O'Dwyer, S.M. Shalet, and M. Egger Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis Lancet 363 2004 1346 1353
16. H.R. Goodarzi, A. Abbasi, M. Saffari, M.B. Tabei, and M.R. Noori Daloii MicroRNAs take part in pathophysiology and pathogenesis of male pattern baldness Mol Biol Rep 37 2010 2959 2965
17. H.R. Goodarzi, A. Abbasi, M. Saffari, M. Fazelzadeh Haghighi, M.B. Tabei, and M.R. Noori Daloii Differential expression analysis of balding and non-balding dermal papilla mircroRNAs in male pattern baldness with mRAP method Br J Dermatol 166 2012 1010 1016
18. L.A. Selth, S. Townley, J.L. Gillis, A.M. Ochnik, K. Murti, and R.J. Macfarlane Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease Int J Cancer 131 2012 652 661
19. R.J. Bryant, T. Pawlowski, J.W. Catto, G. Marsden, R.L. Vessella, and B. Rhees Changes in circulating microRNA levels associated with prostate cancer Br J Cancer 106 2012 768 774
20. S. Yamamura, S. Saini, S. Majid, H. Hirata, K. Ueno, and G. Deng MicroRNA-34a modulates c-Myc transcriptional complexes to suppress malignancy in human prostate cancer cells PLoS One 7 2012 e29722
21. E.L. Wynder, K. Mabuchi, and W.F. Whitmore Jr. Epidemiology of cancer of the prostate Cancer 28 1971 344 360
22. K. Oishi, K. Okada, O. Yoshida, H. Yamabe, Y. Ohno, and R.B. Hayes Case-control study of prostatic cancer in Kyoto, Japan: demographic and some lifestyle risk factors Prostate 14 1989 117 122
23. P. Greenwald, A. Damon, V. Kirmss, and A.K. Polan Physical and demographic features of men before developing cancer of the prostate J Natl Cancer Inst 53 1974 341 346
24. C.C. Hsieh, A. Thanos, D. Mitropoulos, C. Deliveliotis, C.S. Mantzoros, and D. Trichopoulos Risk factors for prostate cancer: a case-control study in Greece Int J Cancer 80 1999 699 703